Related Experiment Videos
Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed
Stuart A Grossman1, Karisa C Schreck1, Karla Ballman2
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
Neuro-Oncology
|April 8, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ketone-targeting Approaches in Glioma.
Hematology/oncology clinics of North America·2026
Pitfalls in 2HG Detection With TE-Optimized MRS at 3T.
Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026
Combined Maximum Tolerated Activity and Lesion-based Dosimetry for Personalized Radioiodine Therapy in Metastatic Differentiated Thyroid Carcinoma: An Early Institutional Experience.
Molecular imaging and radionuclide therapy·2026
Predicting brain tumour enhancement from non-contrast MRI with artificial intelligence: a multicohort, retrospective, diagnostic accuracy study.
The Lancet medical imaging & theranostics·2026
A narrative review of adaptive Phase I/II clinical trial designs for drug combinations in oncology.
Frontiers in oncology·2026